FDA approves Humira’s biosimilar Hulio for rheumatoid arthritis

By NS Healthcare Staff Writer

10 Jul 20

Mylan and Fujifilm Kyowa Kirin Biologics have been working under the partnership since 2018 for the commercialisation of…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Carlyle Group to acquire 20% stake in Piramal Pharma for $490m

By NS Healthcare Staff Writer

29 Jun 20

Piramal Pharma includes Piramal Pharma Solutions, an end-to-end contract development and manufacturing (CDMO) business, Piramal Critical Care, a…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Gilead to acquire 49.9% stake in Pionyr Immunotherapeutics for $275m

By NS Healthcare Staff Writer

24 Jun 20

Pionyr Immunotherapeutics is a privately held pharmaceutical company engaged in developing a research approach, dubbed Myeloid Tuning

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Beximco Pharma rolls out first generic remdesivir to treat Covid-19

By NS Healthcare Staff Writer

22 May 20

Remdesivir has been recently granted the US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) for the…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Menarini to acquire Stemline Therapeutics for $677m

By NS Healthcare Staff Writer

05 May 20

Stemline’s ELZONRIS is an FDA-approved and commercially available targeted therapy to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN)

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Supernus to acquire CNS Portfolio from US WorldMeds for $530m

By NS Healthcare Staff Writer

30 Apr 20

Supernus will acquire APOKYN, MYOBLOC, and XADAGO, along with Apomorphine Infusion Pump, which is currently under late-stage development

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

UK patients set to have faster access to cannabis-based medicines following import law changes

By Jamie Bell

03 Mar 20

In October 2018, then-home secretary Sajid Javid passed a law making the use of medicinal cannabis to treat…

PharmaceuticalsRegulation

Takeda to sell certain non-core assets to Hypera Pharma for $825m

By NS Healthcare Staff Writer

03 Mar 20

The portfolio of non-core assets includes over-the-counter (OTC) and prescription pharmaceutical products and is part of Takeda’s growth…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

Lilly closes $1.1bn acquisition of biopharmaceutical firm Dermira

By NS Healthcare Staff Writer

21 Feb 20

The deal expands Lilly’s portfolio of medicines with the addition of lebrikizumabfor, for atopic dermatitis and QBREXZA for…

PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates

FDA approves new three-in-one pill for reducing blood sugar levels in type 2 diabetes sufferers

By Jamie Bell

28 Jan 20

The new type 2 diabetes treatment is a daily pill containing empagliflozin, linagliptin and extended release metformin hydrochloride

PharmaceuticalsRegulation